Rutherford Health Plc
Withdrawal from AQSE
24 January 2022: Rutherford Health plc (AQSE: RUTH, the "Company"), a healthcare group committed to providing innovative cancer care of the highest quality, confirms that as announced on 11 January 2022, the last day of dealing in the Company's Ordinary Shares on the AQSE Growth Market ("AQSE") will be today, 24 January 2022 and withdrawal of the Company's Ordinary Shares from trading on AQSE will take place at 08.00 on 25 January 2022.
For more information, please contact:
Rutherford Health plc |
Tel: +44 (0) 16 3381 0661 |
Marcus King, Finance Director |
Investors@therutherford.com |
|
|
Grant Thornton (Corporate Adviser) |
Tel: +44 (0) 20 7383 5100 |
Colin Aaronson / George Grainger |
|
|
|
Instinctif Partners |
Tel: +44 207 457 2020 |
Melanie Toyne-Sewell / Jeremy Durrant / Rozi Morris |
Rutherford@Instinctif.com |
|
|
Media House International |
Tel: 07788 414 856 or 0207 710 0020 |
Ramsay Smith |
ramsay@mediahouse.co.uk |
About Rutherford Health plc
Rutherford Health plc is a leading
The Group is listed on the Apex segment of the AQSE Growth Market under the symbol: RUTH. For more information, visit the Group's website: www.rutherfordhealth.com .
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.